免责声明: 本站汇总 FDA、ClinicalTrials.gov、PubMed、SEC EDGAR 等官方公开数据,仅供一般参考,不构成医疗建议、诊断、治疗建议或投资建议。

FDA 510(k)

K-ASSAY CRP(版本2)

K号: K242170 · 2025-04-18

决定日期2025-04-18
产品代码DCK
咨询委员会抱歉,您提供的信息不完整,无法进行翻译。请提供完整的医疗设备监管文本,以便我能够进行准确的翻译。
决定实质等同

器械摘要

K-ASSAY CRP (Ver.2) is the device name listed in this FDA 510(k) record. The listed applicant is Kamiya Biomedical Company, LLC. It received FDA 510(k) clearance on 2025-04-18 under 510(k) number K242170. The device is classified under product code DCK. It was reviewed by the IM advisory panel. FDA Decision: Substantially Equivalent.

常见问题

What is the K-ASSAY CRP (Ver.2)?

K-ASSAY CRP (Ver.2) is a medical device that received FDA 510(k) clearance on 2025-04-18. The listed applicant is Kamiya Biomedical Company, LLC. The 510(k) number is K242170.

When did K-ASSAY CRP (Ver.2) receive FDA 510(k) clearance?

K-ASSAY CRP (Ver.2) received FDA 510(k) clearance on 2025-04-18, under 510(k) number K242170.

Who is the listed applicant for K-ASSAY CRP (Ver.2)?

The FDA 510(k) record lists Kamiya Biomedical Company, LLC as the applicant. This does not by itself establish the device manufacturer.

What is the FDA product code for K-ASSAY CRP (Ver.2)?

The FDA product code for K-ASSAY CRP (Ver.2) is DCK.

相关临床试验

关联记录通过名称、产品代码或其他元数据自动匹配。匹配不意味着已验证临床、科学、企业或监管关系;请查阅链接的官方来源。

相关器械(代码:DCK)

关联记录通过名称、产品代码或其他元数据自动匹配。匹配不意味着已验证临床、科学、企业或监管关系;请查阅链接的官方来源。

官方来源

在 FDA 数据库中查看 →

数据来源于FDA开放API。如需最新且权威的信息,请务必参考官方记录。

↑